SPTBN2 and nasopharyngeal carcinoma, susceptibility to, 1: A descriptive analysis of the known NPCA patients carrying heterozygous de novo SPTBN2 mutations (including the two cases here described) is summarized in Table S1 [4,11,12,15,16,17,18,19].